In general-only here, and beyond drug-therapy, if/when common procedures, first time or re-do, such as angioplasty, with or without stents, or coronary artery bypass graft (CABG) surgey are not deemed feasible, as applicable to the patient, there may/can be other options, that includes non-invasive EECP, laser-based TMR and gene therapy/transfer.
FDA approved non-invasive Enhanced External Counterpulsation (EECP) treatments.
Growing your own so-called "bio-bypass" (collateral vessels) around blockages in the heart, and in the legs It's known as gene therapy/gene transfer, which has been in experimental phases for quite some time now. . As reported, over the last 20 years, gene therapy has moved from pre-clinical animal investigations (animal models) to human clinical studies for many diseases ranging from single gene disorders, to much more complex, multi-factorial, multi-conditional diseases such as dreaded cancer and cardiovascular disorders.
Readers Digest Online - February 2008
An experimental treatment is giving desperately ill heart patients a new lease on life.
A process called angiogenesis. The experimental procedure had shown great promise in two German studies, and the FDA had approved the launch of the first American clinical trial.
The technique involves injecting the heart with a protein called fibroblast growth factor 1 (FGF-1).
"The protein is like a seed that causes new vessels to sprout, creating a network of capillaries and small arteries." FGF-1 occurs naturally in the body.
Good to know, for the primary/secondary prevention of heart attack/brain attack
Epidemiologic studies have revealed risk factors (encompasses some new, novel or emerging) for atherosclerosis, typically affecting carotid, coronary and peripheral arteries, which includes age, gender, genetics (gene deletion, malfunction or mutation) , diabetes, smoking (includes second and thirdhand), inactivity, obesity (a global epidemic, "globesity"), high blood pressure (hypertension), Low HDL (now questionable, according to recent studies) high LDL, small, dense LDL, RLP (remnant lipoprotein), high Lp(a), high ApoB, high Lp-PLA2, high triglycerides, HDL2b, high homocysteine (now questionable), and high C-reactive protein (CRP/hs-CRP).
The hospital/medical center you choose can make a difference...a critical difference. Choose wisely!
The opinions expressed in WebMD Communities are solely those of the User, who may or may not have medical or scientific training. These opinions do not represent the opinions of WebMD. Communities are not reviewed by a WebMD physician or any member of the WebMD editorial staff for accuracy, balance, objectivity, or any other reason except for compliance with our Terms and Conditions. Some of these opinions may contain information about treatments or uses of drug products that have not been approved by the U.S. Food and Drug Administration. WebMD does not endorse any specific product, service or treatment.
Do not consider Communities as medical advice. Never delay or disregard seeking professional medical advice from your doctor or other qualified healthcare provider because of something you have read on WebMD. You should always speak with your doctor before you start, stop, or change any prescribed part of your care plan or treatment. WebMD understands that reading individual, real-life experiences can be a helpful resource, but it is never a substitute for professional medical advice, diagnosis, or treatment from a qualified health care provider. If you think you may have a medical emergency, call your doctor or dial 911 immediately.